1. R&D Facts
• More than $120 billion worldwide is spent on
pharmaceutical R&D
• Most of the money is spent by US or core
European companies (for example France and
Germany)
• Without clinical cost reduction, pharmaceutical
and healthcare industry are headed toward
doomsday scenario
• CROs market share of R&D has grown in double
digits over last several years
• Asian and non-core European shares of clinical
trial market has grown from 16% in 2004 to more
than 50% in 2012

2. PharmSages Advantage_Pharma and Biotech
• Independent and unbiased review of client’s
projects by PharmaSages consultants
• Part-time consultants do the job instead of FTEs-
resulting significant savings for clients
• Bids from multiple CROs and/or hospitals without
disclosing client’s identity
• Contract and budget negotiations with CROs
• Assistance with FDA compliance and filings
• Document preparation and review

3. PharmSages Advantage_CROs and Hospitals
• Local representations to non-US CROs which can
help them reduce costs by reducing their US
employees and their US travel
• Provide CROs with clinical and non-clinical
consultants
• Help CROs in acquiring clinical and non-clinical
expertise
• Contract and budget negotiations with CROs
• Assistance with FDA compliance and filings

4. PharmSages_Snapshot of Document Database

5. Contact us
Ajay Shrivastava, CEO
PharmaSages
58 Magnolia Lane
Princeton, NJ 08540
Phone: (609)423-7602
E-mail:asbiopro@pharmasages.com
Web: www.pharmasages.com